Northwest Biotherapeutics | NWBO - Vermögenswerte





Vermögenswerte Veränderung Datum
Agenus USD 226.8M 7.09M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Celldex Therapeutics USD 582.98M 65.46M 2025-12
Eisai JPY 1.49T 48.22B 2025-12
Infinity Pharmaceuticals USD 21.23M 8.72M 2023-06
Merck USD 129.55B 12.02B 2025-09
Northwest Biotherapeutics USD 30.61M 1.06M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Plus Therapeutics USD 16.32M 2.34M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12